Back Cover: Nucleus‐specific RNAi Nanoplatform for Targeted Regulation of Nuclear Lncrna Function and Effective Cancer Therapy (EXP2 5/2022)
Exploration(2022)
摘要
A nucleus-specific RNAi nanoplatform was developed by Xu et al. for targeted regulation of nuclear lncRNA function and effective cancer therapy. This nanoplatform could respond to the endosomal pH to expose NTPA/siRNA complexes for the nucleus-specific siRNA delivery, leading to a significant inhibition of nuclear lncNEAT2 expression and tumor growth.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要